0001437749-23-035158.txt : 20231221 0001437749-23-035158.hdr.sgml : 20231221 20231221194441 ACCESSION NUMBER: 0001437749-23-035158 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231219 FILED AS OF DATE: 20231221 DATE AS OF CHANGE: 20231221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kamke Trent G CENTRAL INDEX KEY: 0001365739 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33092 FILM NUMBER: 231506857 MAIL ADDRESS: STREET 1: 61 WILLOWDEAN AVENUE CITY: WEST ROXBURY STATE: MA ZIP: 02132 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC CENTRAL INDEX KEY: 0001158895 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 781-221-2266 MAIL ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 rdgdoc.xml FORM 4 X0508 4 2023-12-19 0001158895 LEMAITRE VASCULAR INC LMAT 0001365739 Kamke Trent G C/O LEMAITRE VASCULAR , INC. 63 SECOND AVENUE BURLINGTON MA 01803 1 Senior V. P., Operations 0 Common Stock 2023-12-19 4 M 0 9 0 A 8122 D Common Stock 2023-12-19 4 F 0 79 56.06 D 8043 D Common Stock 2023-12-19 4 M 0 1 0 A 8044 D Common Stock 2023-12-20 4 M 0 2 0 A 8046 D Common Stock 2023-12-20 4 F 0 49 54.85 D 7997 D Dividend Equivalent Rights 2023-12-19 4 M 0 9 0 D Common Stock 9 0 D Dividend Equivalent Rights 2023-12-19 4 M 0 1 0 D Common Stock 1 0 D Dividend Equivalent Rights 2023-12-20 4 M 0 2 0 D Common Stock 2 8.6411 D Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Represents shares acquired from the release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 19, 2018. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 20, 2019. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. /s/ David. Hissong 2023-12-21